Selank drug interactions: what's known and what isn't

Last updated 2026-07-26

Has anyone actually studied Selank drug interactions?

No. Search Russian pharmacology journals, PubMed, or the clinicaltrials.gov registry and you won't find a dedicated drug-drug interaction study for Selank, not with SSRIs, not with benzodiazepines, not with alcohol, not with anything else people commonly ask about. This is the single most useful thing to understand before reading anything else on this page. Selank was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and studied through Russian clinical trials in the 2000s and 2010s, mostly for generalized anxiety disorder ^[1]. Those trials measured efficacy and tolerability of Selank alone or against comparator drugs like Phenazepam (a Russian benzodiazepine) ^[2]. They were not designed to test what happens when Selank is combined with other medications a patient might already be taking. That gap has never been closed by a follow-up study, in Russia or anywhere else. So anything you read about Selank interactions, including this article, is reasoning from the peptide's pharmacology and from how it behaved in trials where interacting drugs weren't the variable being tested. That's a legitimate way to think about risk. It is not the same as having interaction data.

Why does Selank's chemistry make interactions less predictable to study?

Selank is a heptapeptide, a chain of seven amino acids, structurally derived from the immune signaling molecule tuftsin with three extra amino acids added for stability ^[3]. Small-molecule drugs like SSRIs or benzodiazepines are metabolized largely through liver cytochrome P450 enzymes (CYP3A4, CYP2D6, and others), and that's where most classic drug interactions happen: one drug blocks or speeds up the enzyme that breaks down another. Peptides don't generally work that way. Selank is thought to be broken down by peptidases, enzymes that cut peptide bonds, into smaller fragments and eventually free amino acids ^[1]. There's no published evidence that Selank induces or inhibits CYP450 enzymes. That absence of a mechanism is reassuring in a limited sense: it lowers the prior probability of the kind of interaction that makes, say, grapefruit juice dangerous with certain statins. But absence of a known mechanism is not the same as absence of risk. Peptides can still have additive pharmacodynamic effects, meaning two substances pushing the same biological system in the same direction, even if neither one changes how the other is metabolized. That's the more realistic category of concern here.

Can Selank be combined with SSRIs or other antidepressants?

There's no controlled human data on combining Selank with SSRIs, SNRIs, or other antidepressants. Russian researchers have proposed Selank affects serotonin and GABA signaling and modulates brain-derived neurotrophic factor (BDNF) expression, based on animal studies ^[4], which is part of why it's framed as an anxiolytic with antidepressant-adjacent properties. If that mechanism is right, at least in outline, then combining Selank with an SSRI is a case of two agents nudging serotonergic tone in a possibly similar direction. That doesn't mean serotonin syndrome is a realistic risk the way it is with, say, combining an SSRI and an MAOI. Selank isn't a monoamine reuptake inhibitor or an MAO inhibitor. But it does mean nobody has actually checked whether the combination produces additive anxiolytic effect, no effect, or unpredictable results, and anyone on a prescribed antidepressant should treat this as an open question, not a settled one. The honest position: this hasn't been tested. If you're on an SSRI or SNRI prescribed by a physician, loop that physician in before adding a peptide with an unclear interaction profile, even one with a benign-looking mechanism.

Is it dangerous to combine Selank with benzodiazepines or alcohol?

This is the comparison that actually has some direct data behind it, because several Russian trials compared Selank to Phenazepam (a benzodiazepine used in Russia, chemically related to drugs like clonazepam) as an anxiolytic ^[2][5]. Selank showed comparable anxiolytic effect to Phenazepam in some of these trials without the sedation, motor impairment, or dependence liability associated with benzodiazepines ^[2]. That's a comparison, not a combination study. Nobody tested taking Selank and Phenazepam (or Selank and Xanax, or Selank and alcohol) together. The concern with combining a CNS-active peptide and a benzodiazepine or alcohol isn't a sharp, well-characterized interaction; it's the generic worry that layering multiple substances that act on anxiety and arousal systems makes the net effect harder to predict, and makes it harder to tell which substance is responsible if something goes wrong (excess sedation, unusual mood change, blood pressure shifts). Given that Selank trials themselves reported it as generally well tolerated without heavy sedation ^[2][6], stacking it with a benzodiazepine or with alcohol doesn't have an obvious catastrophic mechanism attached. But 'no obvious mechanism' from a company writing about its own literature gap is not a green light. If you're prescribed a benzodiazepine, this is a conversation for your prescriber, not a guess.

Does Selank interact with stimulants like Adderall or with caffeine?

No study has looked at this combination either. People researching Selank for focus, rather than anxiety, often stack it with stimulant medications or with caffeine, and the logic seems intuitive: Selank calms without sedating, stimulants sharpen focus, so together you get calm focus. The honest answer is that this pairing is popular in anecdote and untested in any clinical sense. Selank's proposed mechanism touches BDNF expression and serotonergic/GABAergic tone ^[4], not the dopamine and norepinephrine systems that stimulants act on directly, so there isn't an obvious pharmacodynamic collision. That's a different claim from a research is available. Anyone combining Selank with prescription stimulants should watch for the basics: unusual heart rate changes, blood pressure shifts, or mood effects that don't track with either substance alone, and should mention the combination to whoever prescribes the stimulant. Selank is sometimes confused with its sibling peptide Semax, and this is one context where the confusion matters. Semax has a more stimulant-adjacent reputation (it's studied for cognitive and neuroprotective effects and used off-label for focus in Russia), while Selank leans anxiolytic. If you're trying to reason about interaction risk with a stimulant, you should be clear on which peptide you're actually asking about. See our selank vs semax comparison for the practical differences.

What about combining Selank with other nootropics or supplements?

There's no dedicated safety data on Selank plus racetams, plus other peptides, or plus common supplements like L-theanine, ashwagandha, or magnesium. Most of what circulates online is user-reported stacking, not clinical evidence, and should be labeled as such. The practical risk with stacking Selank alongside several other nervous-system-active supplements isn't a specific known interaction; it's that if you take five things at once and something changes (mood, sleep, appetite, blood pressure), you have no way to isolate which one caused it. That's not a Selank-specific problem, it's a general problem with polypharmacy in the unregulated supplement and research-peptide space, and it's worth taking seriously precisely because nobody, including Selank's own Russian trial sponsors, has tested these combinations. If you're going to experiment, the more useful discipline is sequential, not simultaneous: introduce one variable at a time, track it for a couple of weeks, and only then consider adding something else.

Does the FDA regulate Selank, and does that affect interaction safety data?

No. Selank is not an FDA-approved drug. It has no FDA monograph, no approved labeling, and no FDA-reviewed interaction data, because it has never gone through the FDA drug approval pathway described in the Federal Food, Drug, and Cosmetic Act . In the United States it exists in a research-chemical and compounding gray zone; some compounding pharmacies prepare it under a prescription, typically for nasal spray or injectable use, using bulk peptide material. Russia's regulatory history is different and shouldn't be conflated with FDA approval. Selank has Russian state registration as a pharmaceutical product and is sold there under prescription, with Russian-language clinical trials supporting its listed indications for anxiety disorders ^[1]. Russian registration reflects Russia's own regulatory standards and trial requirements, which differ from FDA standards in trial design, blinding practices, and publication norms. It is a real regulatory approval in its home country. It is not equivalent evidence to an FDA-reviewed New Drug Application, and readers should hold both facts at once rather than picking one to make Selank look either more or less legitimate than it is. Because there's no FDA oversight, there's also no FDA-mandated post-market interaction surveillance, no MedWatch-style adverse event reporting requirement tied to Selank specifically, and no official interaction labeling anyone in the US can point to. That absence is structural, not a reflection of some hidden research.

What do the Russian clinical trials actually say about safety, and what are the limits of that evidence?

Russian trials on Selank, largely from the 2000s through the 2010s, generally report it as well tolerated with a low rate of adverse effects, most commonly mild and transient things like short-lived changes in energy or mild nasal irritation when delivered intranasally ^[1][6]. Several trials frame Selank favorably against Phenazepam specifically because it lacked the sedation, cognitive dulling, and dependence risk associated with benzodiazepine use ^[2]. Here's the honest limitation: most of these trials are published in Russian-language journals, often with sample sizes in the dozens to low hundreds, and they haven't been independently replicated by research groups outside Russia in peer-reviewed Western journals. That doesn't make the findings false. It does mean the evidence base hasn't gone through the kind of independent, multi-site replication that Western regulators and most Western physicians consider a baseline standard before treating a safety profile as settled. A tolerability finding from one country's trial network, however many trials, is a real data point, not a global consensus. For drug interactions specifically, even the most favorable reading of this literature doesn't help much, because tolerability data collected in trials that excluded polypharmacy tells you almost nothing about what happens when Selank meets a second CNS-active drug. If you want the fuller picture on Selank's efficacy evidence and its quality, our Selank overview covers that in depth, and our side effects page covers the tolerability data specifically.

How should someone weigh Selank interaction risk if they're on prescription medication?

Given the total absence of formal interaction studies, the most defensible approach is to treat Selank the way you'd treat any unregulated substance with an unclear-but-plausible mechanism: assume a low but nonzero interaction risk with CNS-active drugs, and get real medical input before combining it with anything you're prescribed, especially antidepressants, benzodiazepines, mood stabilizers, or antipsychotics. A table helps organize what's actually known versus assumed. | Combination | Direct study? | What's known | Practical read |

What should someone sourcing Selank do to manage interaction risk practically?

Sourcing matters here more than most people assume, because interaction risk isn't just pharmacological, it's also about purity and dosing accuracy. An unverified vial of research-grade peptide with unknown concentration or contaminants adds a second layer of unpredictability on top of the drug interaction question itself: if you don't know what's actually in the vial, you can't reason clearly about what it might do alongside another medication. Working with a source that goes through a provider-reviewed process (a prescribing clinician evaluates your history, including current medications, before a prescription is written) at least puts a real medical checkpoint between you and the interaction question, rather than leaving it entirely to self-research. Selank Co's guide to buying Selank walks through what that provider-reviewed route looks like and names the compounding pharmacy partners that fulfill prescriptions, which is a materially different risk profile than ordering unregulated research-chemical vials with no clinician review at all. Whatever the source, dose matters too. Russian trials generally used total daily doses in the range of 1500 to 3000 micrograms delivered intranasally, split across multiple administrations ^[1][2]. Our Selank dosage guide covers that range and how it was used in the trials it comes from. Higher, self-directed doses on top of an existing medication regimen widen whatever interaction risk exists, purely by increasing total exposure.

Frequently asked questions

Can I take Selank with my antidepressant?

There's no clinical trial testing this combination. Selank's proposed mechanism touches serotonergic signaling, which theoretically overlaps with SSRIs and SNRIs, but nothing catastrophic has been reported and nothing has been formally tested either. Talk to the prescriber managing your antidepressant before adding Selank.

Is Selank safe with alcohol?

No study has tested Selank combined with alcohol. Russian trials describe Selank as low-sedation compared to benzodiazepines, which suggests less obvious risk than combining alcohol with something like Phenazepam, but 'less obvious risk' is not the same as tested safety.

Does Selank interact with benzodiazepines like Xanax or Klonopin?

Selank has been compared to the Russian benzodiazepine Phenazepam in separate trials, generally favorably on sedation and dependence risk, but the two were never studied as a combination. Anyone on a prescribed benzodiazepine should discuss adding Selank with their prescriber rather than assuming safety.

Can Selank be combined with stimulants or ADHD medication?

No formal data exists. Selank's proposed mechanism (serotonergic and GABAergic modulation, BDNF effects) differs from the dopamine/norepinephrine pathways stimulants act on, so an obvious pharmacodynamic clash isn't apparent, but this combination is untested and should be discussed with the stimulant's prescriber.

Is Selank FDA-approved, and does that mean its interactions are documented?

No. Selank has no FDA approval and no FDA-reviewed labeling or interaction data. It has Russian state registration and Russian clinical trial support for anxiety indications, which is a real but separate regulatory standard, not equivalent to FDA review.

What's the difference between Selank and Semax for interaction risk?

They're related peptides but not interchangeable. Selank is anxiolytic-leaning with a proposed serotonergic/GABAergic and BDNF mechanism; Semax is studied more for cognitive and neuroprotective effects with a different proposed mechanism. Neither has formal interaction studies, and conflating the two when researching interactions risks misapplying findings from one to the other.

Are there known dangerous drug interactions with Selank?

None have been documented in Russian or Western literature, but that's because no dedicated interaction study exists, not because safety has been confirmed. The honest answer is that dangerous interactions haven't been ruled out; they simply haven't been looked for systematically.

Can I combine Selank with other peptides or nootropics?

There's no safety data on Selank combined with other peptides or nootropic supplements. The practical risk of stacking multiple untested substances is that if something changes, you can't tell which substance caused it. Introducing one variable at a time is the more informative approach.

Does Selank affect liver enzymes the way many prescription drugs do?

There's no published evidence that Selank induces or inhibits cytochrome P450 liver enzymes, the pathway responsible for many classic drug interactions. As a peptide, it's thought to be broken down by peptidases rather than metabolized through that system, which lowers but doesn't eliminate interaction concern.

Should I tell my doctor if I'm taking Selank alongside prescription medication?

Yes. Even though Selank isn't FDA-approved and won't appear in standard drug interaction checkers, your prescriber needs the full picture of everything you're taking, including research peptides, to make informed decisions about your other medications.

Is the Russian research on Selank interactions reliable?

The Russian trials that exist focus on efficacy and general tolerability, not drug-drug interactions specifically. They're real clinical data but haven't been independently replicated in Western peer-reviewed journals, and they don't address polypharmacy, so they can't answer most interaction questions directly.

What should I do if I want to try Selank while on other medications?

Get a provider-reviewed evaluation before starting. A clinician who reviews your medication history can flag theoretical concerns specific to your regimen, which is a meaningfully different safety check than self-directed research-chemical sourcing with no clinical review.

Sources

1. Institute of Molecular Genetics (Russian Academy of Sciences), Selank development and clinical trial summaries: Selank was developed by the Institute of Molecular Genetics and studied through Russian clinical trials primarily for anxiety disorders
2. PubMed, comparative trial of Selank and Phenazepam in generalized anxiety disorder: Selank showed comparable anxiolytic effect to the benzodiazepine Phenazepam without similar sedation or dependence liability
3. PubMed, Selank effects on BDNF expression and monoamine systems in animal models: Selank is proposed to affect serotonergic and GABAergic signaling and modulate BDNF expression based on animal studies
4. PubMed, Phenazepam pharmacology and use as a benzodiazepine comparator: Phenazepam is a benzodiazepine used in Russia and was used as a clinical comparator to Selank
5. PubMed, tolerability and adverse effect profile of Selank in clinical use: Selank trials report low rates of mild, transient adverse effects such as nasal irritation with intranasal use
6. U.S. Food and Drug Administration, New Drug Application (NDA) process overview under 21 CFR Part 314: FDA drug approval requires review under the Federal Food, Drug, and Cosmetic Act, a pathway Selank has never gone through